Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.John C. Byrd, C. D. Bloomfield, D C Arthur et al.|Journal of Clinical Oncology|1997Cited by 236